Clinical Trials on Pudendal Nerve in United Kingdom

Total 5564 results

Vitaccess Ltd
Royal Marsden NHS Foundation Trust; Melanoma UK

Completed

The Impact of Melanoma and Drug Treatment in the Real World

Melanoma

United Kingdom
Moletest Scotland Ltd
NHS Lanarkshire; Digital Health & Care Institute

Completed

Moletest Clinical Study in Scotland

Melanoma

United Kingdom
M.D. Anderson Cancer Center

Recruiting

Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study

Chronic Knee Pain | Peripheral Nerve Stimulation | Genicular Nerves

United States
The Christie NHS Foundation Trust
University of Manchester

Recruiting

Serial Tumour Biopsies and Blood Biomarkers in Melanoma

Melanoma

United Kingdom
Imperial College London

Completed

Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI

Glioma

United Kingdom
NHS Grampian
University of Aberdeen

Recruiting

FCI in Post-operative Low Grade Gliomas

Glioma

United Kingdom
King's College Hospital NHS Trust

Recruiting

Post-operative Imaging in High Grade Glioma: is Management Influenced? (PIGMI)

Glioma

United Kingdom
King's College Hospital NHS Trust
Ampersand Health Ltd; Neuroendocrine Cancer UK

Recruiting

Mobile Application to Collect PRO Data in NET Patients

Neuroendocrine Neoplasms (Tumours)

United Kingdom
Immodulon Therapeutics Ltd
Theradex; HCA International Limited

Completed

A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients

Melanoma

United Kingdom
Imperial College London
Biocompatibles UK Ltd, a BT International group company

Recruiting

TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets (ArTisaN)

Neuroendocrine Tumors | Liver Metastases

United Kingdom
Immodulon Therapeutics Ltd

Terminated

A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001

Malignant Melanoma

United Kingdom
Julie Dawson
University of East Anglia

Suspended

CAVA: Dizziness Trial (CAVA)

Benign Paroxysmal Positional Vertigo | Vestibular Migraine | Meniere's Disease | Recurrent Vestibulopathy

United Kingdom
Orlucent, Inc
University Hospitals, Leicester; NHS Tayside; University of Dundee; NHS Greater... and other collaborators

Completed

Investigating the Clinical Utility of the MDS (OMS002_UK)

Melanoma | Skin Lesion | Moles

United Kingdom
Bristol-Myers Squibb

Completed

Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United Kingdom

Melanoma

United Kingdom
King's College Hospital NHS Trust
King's College London

Not yet recruiting

Establishing Radiolabelled PSMA as a Target for Glioma Treatment

Glioma, Malignant

United Kingdom
Guy's and St Thomas' NHS Foundation Trust

Completed

Reliability of Functional Outcome Measures in Neurofibromatosis 1

Neurofibromatosis 1, NF1

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
University of Oxford; National Institute for Health Research, United Kingdom; Oxford University Hospitals NHS Trust

Completed

Continuous vs Intermittent Dabrafenib Plus Trametinib in BRAFV600 Mutant Stage 3 Unresectable or Metastatic Melanoma (INTERIM)

Melanoma

United Kingdom
University of Oxford

Unknown

Docetaxel With or Without AZD6244 in Melanoma (DOC-MEK)

Melanoma

United Kingdom
Guy's and St Thomas' NHS Foundation Trust

Recruiting

Reliability of Functional Outcome Measures in Neurofibromatosis 1: Test- Retest

Neurofibromatosis Type 1

United Kingdom
University College, London
University of Oxford; Cancer Research UK

Active, not recruiting

[18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain Biopsy (FIG)

Glioma

United Kingdom
CCTU- Cancer Theme
Pierre Fabre Medicament

Not yet recruiting

Perioperative Encobini in BRAFV600 Mutant Stage III (B/C/D) or Oligometastatic Stage IV Melanoma (PREMIUM)

Melanoma | Cancer

United Kingdom
NHS Greater Glasgow and Clyde
University of Waterloo

Unknown

Vision in Children Born to Opioid-dependent Methadone-maintained Mothers (VINCH)

Strabismus | Vision Disorders | Binocular Vision Disorder | Nystagmus

United Kingdom
University of Surrey

Completed

Holistic Needs Assessments in Patients With Melanoma

Melanoma | Unsatisfied Needs

United Kingdom
Royal Marsden NHS Foundation Trust

Unknown

The Identification of Novel Prognostic Markers in Melanoma

Malignant Melanoma

United Kingdom
Imperial College London
Advanced Accelerator Applications International SA

Recruiting

Lutathera and ASTX727 in Neuroendocrine Tumours (LANTana)

Neuroendocrine Tumors

United Kingdom
Imperial College London

Recruiting

Use of Non-invasive Optical Analysis in Neurosurgery

Glioma | Meningioma | Brain Metastases | Schwannoma | Brain Tumour

United Kingdom
Ipsen

Completed

Non Interventional Post Marketing Programme in Neuroendocrine Tumours

Neuroendocrine Tumors

United Kingdom
University of Aberdeen

Recruiting

Nerve Composition of Human Lumbar Dorsal Primary Rami and Its Medial Branch

Nerve Degeneration | Lumbar Facet Arthrosis

United Kingdom
Cambridge University Hospitals NHS Foundation Trust

Recruiting

Surgically Induced Neurological Deficits in Glioblastomas (SIND Study) (SIND)

Glioblastoma

United Kingdom
Royal Marsden NHS Foundation Trust

Completed

TITAN (Tumoural Injection of T-VEC and Isolated Limb Perfusion) (TITAN)

Melanoma and Sarcoma

United Kingdom
University College, London

Recruiting

CAR T Cells to Target GD2 for DMG (CARMIGO)

Diffuse Midline Glioma, H3 K27M-Mutant

United Kingdom
Royal Free Hospital NHS Foundation Trust
Merck Sharp & Dohme LLC; University College, London

Completed

Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab (PASIP)

Melanoma | Neoplasms

United Kingdom
Imperial College London

Recruiting

[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM) (FAM-GBM)

Glioblastoma Multiforme of Brain

United Kingdom
University of Aberdeen
Cancer Research UK

Completed

Achieving Self-directed Integrated Cancer Aftercare (ASICA) in Melanoma (ASICA)

Melanoma

United Kingdom
University of Plymouth

Completed

Advanced Glycation End Products as a Biomarker for Accelerated Ageing

Primary Open Angle Glaucoma | Ocular Hypertension | Normal Tension Glaucoma

United Kingdom
Boston Scientific Corporation
University of Birmingham

Terminated

Study of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme.

Glioma

United Kingdom
North Bristol NHS Trust

Withdrawn

Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme

Glioblastoma Multiforme

United Kingdom
CCTU- Cancer Theme
Cambridge University Hospitals NHS Foundation Trust; Cancer Research UK; Experimental...

Active, not recruiting

Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study) (PRaM-GBM)

High Grade Glioma

United Kingdom
Merz Pharmaceuticals GmbH

Completed

Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus

Nystagmus, Acquired | Nystagmus, Congenital Idiopathic

United Kingdom
The Christie NHS Foundation Trust
National Institute for Health Research, United Kingdom

Terminated

TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment (METILDA)

Metastatic Melanoma

United Kingdom
Oxford University Hospitals NHS Trust
University of Southampton

Recruiting

MoleGazer Development Feasibility Study

Melanoma (Skin) | Moles Multiple Benign

United Kingdom
Mount Vernon Cancer Centre at Mount Vernon Hospital

Unknown

Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma

Melanoma (Skin)

United Kingdom
Leeds Cancer Centre at St. James's University Hospital

Unknown

Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy

Melanoma (Skin)

United Kingdom
University of Manchester

Completed

Mechanism of Action of Transcranial Direct Current Stimulation in Neurofibromatosis Type 1

Neurofibromatosis 1

United Kingdom
Barts & The London NHS Trust
Harvard Medical School (HMS and HSDM); Brigham and Women's Hospital

Unknown

Neurosurgical Transitional Care Programme (TCP)

Brain Diseases | Spinal Diseases | Brain Cancer | Brain Tumor | Surgery | Spinal Stenosis | Aneurysm | Fusion of Spine | Brain Metastases | Spinal Fusion | Trigeminal Neuralgia | Brain Tumor, Recurrent | Hydrocephalus | Spinal Cord Neoplasms | Brain Lesion | SPINAL Fracture | Brain Pathology | Spinal Instability | Spinal Curvature | Chiari; Net and other conditions

United Kingdom
Manchester University NHS Foundation Trust
Manchester Metropolitan University

Completed

Whole-body Vibration in Children With Neurofibromatosis Type 1

Muscle Weakness | Neurofibromatosis Type 1

United Kingdom
University College, London
Bristol-Myers Squibb

Terminated

A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma (NeAT Glio)

Glioblastoma

United Kingdom
University of Manchester

Completed

Non-invasive Stimulation in Neurofibromatosis Type 1 (tDCS is NF1)

Neurofibromatosis 1

United Kingdom
Leeds Cancer Centre at St. James's University Hospital

Unknown

Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma

Melanoma (Skin)

United Kingdom
Royal Marsden NHS Foundation Trust

Unknown

A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers (PaC-MAn)

Pancreatic Adenocarcinoma

United Kingdom

Clinical Trials on Pudendal Nerve in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations